Geneos Wealth Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

$2.6 Billion
Q3 2024

A detailed history of Geneos Wealth Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 687 shares of REGN stock, worth $482,170. This represents 0.03% of its overall portfolio holdings.

Number of Shares

687

Previous 806 14.76%

Holding current value

$482,170

Previous $847,000 14.76%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $121,866 - $143,009	-119 Reduced 14.76%	687 $722,000
Q2 2024 Jul 23, 2024	SELL	$883.2 - $1071.19 $35,328 - $42,847	-40 Reduced 4.73%	806 $847,000
Q1 2024 May 03, 2024	SELL	$902.69 - $993.35 $16,248 - $17,880	-18 Reduced 2.08%	846 $814,000
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $32,557 - $37,031	-42 Reduced 4.64%	864 $758,000
Q3 2023 Oct 11, 2023	SELL	$692.45 - $844.37 $70,629 - $86,125	-102 Reduced 10.12%	906 $745,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $20,300 - $24,080	-29 Reduced 2.8%	1,008 $724,000
Q1 2023 Apr 25, 2023	SELL	$680.49 - $826.97 $33,344 - $40,521	-49 Reduced 4.51%	1,037 $852,000
Q4 2022 Jan 30, 2023	SELL	$705.89 - $766.39 $26,117 - $28,356	-37 Reduced 3.29%	1,086 $783,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $4,591 - $5,794	8 Added 0.72%	1,123 $773,000
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $33,997 - $45,808	-62 Reduced 5.27%	1,115 $659,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $17,853 - $20,952	-30 Reduced 2.49%	1,177 $822,000
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $12,500 - $15,432	-23 Reduced 1.87%	1,207 $762,000
Q3 2021 Nov 09, 2021	SELL	$574.03 - $680.96 $109,639 - $130,063	-191 Reduced 13.44%	1,230 $702,000
Q2 2021 Jul 08, 2021	SELL	$472.8 - $558.54 $65,246 - $77,078	-138 Reduced 8.85%	1,421 $829,000
Q1 2021 Jun 17, 2021	SELL	$446.73 - $548.2 $23,229 - $28,506	-52 Reduced 3.23%	1,559 $750,000
Q4 2020 May 19, 2021	BUY	$478.3 - $607.98 $605,049 - $769,094	1,265 Added 365.61%	1,611 $767,000
Q3 2020 Sep 07, 2021	BUY	$544.75 - $658.21 $2,723 - $3,291	5 Added 1.47%	346 $198,000
Q2 2020 Sep 07, 2021	SELL	$493.32 - $643.92 $96,690 - $126,208	-196 Reduced 36.5%	341 $208,000
Q1 2020 Sep 07, 2021	BUY	$336.18 - $494.43 $6,723 - $9,888	20 Added 3.87%	537 $245,000
Q1 2019 Sep 07, 2021	BUY	$372.08 - $439.57 $2,604 - $3,076	7 Added 1.37%	517 $212,000
Q4 2018 Sep 07, 2021	SELL	$335.82 - $403.04 $13,432 - $16,121	-40 Reduced 7.27%	510 $184,000
Q2 2018 Sep 07, 2021	SELL	$284.6 - $344.99 $4,838 - $5,864	-17 Reduced 3.0%	550 $189,000
Q3 2017 Sep 07, 2021	SELL	$431.38 - $504.0 $431 - $504	-1 Reduced 0.18%	567 $253,000
Q2 2017 Sep 07, 2021	SELL	N/A	-10 Reduced 1.73%	568 $278,000
Q1 2017 Sep 07, 2021	SELL	N/A	-11 Reduced 1.87%	578 $223,000
Q3 2016 Sep 07, 2021	BUY	N/A	11 Added 1.9%	589 $236,000
Q1 2016 Sep 07, 2021	BUY	N/A	578	578 $234,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History